Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha
Elliott MJ, Maini RN, Feldmann M et al. Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha. Arthritis Rheum 1993;36:1681-90.
Infliximab and methotrexate in the treatment of rheumatoid arthritis
Anti-tumor necrosis factor trial in rheumatoid arthritis with concomitant Therapy Study Group
Lipsky PE, van der Heijde DMFM, St Clair EW et al. Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-tumor necrosis factor trial in rheumatoid arthritis with concomitant Therapy Study Group. N Engl J Med 2000;343:1594-602.
Repeated infusions of infliximab, a chimeric anti-TNFalpha monoclonal antibody, in patients with active spondyloarthropathy: One year follow up
Kruithof E, Van der Bosch F, Baeten D, Herssens A et al. Repeated infusions of infliximab, a chimeric anti-TNFalpha monoclonal antibody, in patients with active spondyloarthropathy: one year follow up. Ann Rheum Dis 2002;61:207-12.
Etanercept in Wegener's granulomatosis: A six month open-label trial to evaluate safety
Stone J, Uhlfelder M, Hellmann D, Crook S, Bedocs N, Hoffman G. Etanercept in Wegener's granulomatosis: a six month open-label trial to evaluate safety. Arthritis Rheum 2000; 43 (Suppl.) : S404.